Pep­tide man­u­fac­tur­er Mytide Ther­a­peu­tics names Mar­ti­na Diek­mann as CEO

Mass­a­chu­setts-based pep­tide man­u­fac­tur­er Mytide Ther­a­peu­tics has named a mem­ber of its ad­vi­so­ry board, Mar­ti­na Diek­mann, as its new CEO.

Diek­mann will be tak­ing over for …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER